APA (7th ed.) Citation

Praguylertluck, W., Kaewdech, A., Chamroonkul, N., Piratvisuth, T., & Sripongpun, P. Effect of switching from prior Nucleos(t)ide Analogue(s) to Tenofovir alafenamide on lipid profile and cardiovascular risk in patients with Chronic Hepatitis B. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Praguylertluck, Witchayaporn, Apichat Kaewdech, Naichaya Chamroonkul, Teerha Piratvisuth, and Pimsiri Sripongpun. Effect of Switching from Prior Nucleos(t)ide Analogue(s) to Tenofovir Alafenamide on Lipid Profile and Cardiovascular Risk in Patients with Chronic Hepatitis B. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Praguylertluck, Witchayaporn, et al. Effect of Switching from Prior Nucleos(t)ide Analogue(s) to Tenofovir Alafenamide on Lipid Profile and Cardiovascular Risk in Patients with Chronic Hepatitis B. Public Library of Science (PLoS).